DAILY MARKET WRAP
Wall Street Idles at Resistance as Fed Silence, China's Slowdown and an Insider-Selling Wave Test the Six-Year Bull
Key desk takeaways
- ▸Soft U.S. retail sales trimmed Fed rate bets, lifting European equities and gold; Goldman still sees the Fed on hold in September as the S&P 500 prints records
- ▸China's July data missed hard — industrial output slowed to 4.5% — while Japan's 1.1% annualised Q2 GDP masked weak capex and consumption
- ▸Smart money splintered on Nvidia as the AI capex cycle nears $600bn; Nvidia trimmed its OpenAI Ohio backstop to $120bn and hyperscaler credit became the new risk vector
- ▸A broad insider-selling wave across US tech, healthcare and media offered a late-cycle tell, partially offset by a projected $1.4tn buyback wave
- ▸a2 Milk profit collapsed 44% on China supply disruption; Australian earnings season turned defensive as JB Hi-Fi's guidance miss overshadowed strong Aurizon and BlueScope results
- ▸Buy List 2026 closed at €111,844 (+1.68%), led by Maersk +26.4% and Vestas +14.8%, with Vonovia -16.0% the dominant drag
Markets spent the session in a holding pattern, with index futures drifting and cross-asset trends turning listless as investors declined to take fresh risk ahead of the Federal Reserve. Soft U.S. retail sales did most of the day's work, trimming rate expectations at the margin, lifting European equities and pushing gold higher, while the dollar stabilised after a run of choppy sessions. Goldman Sachs reiterated its call for the Fed to stay on hold in September even as the S&P 500 printed another record — a combination that captures the market's current posture: fully valued, not yet frightened, and short of a catalyst. Beneath the macro narrative, a distinctly political trade is building around the Warsh succession story, with rates desks beginning to price the possibility of a more accommodative Fed chair in 2027.
The growth data offered less comfort. China's July prints missed across the board, with industrial output decelerating to 4.5% and reigniting the stimulus debate that Beijing has spent the year deferring. Japan's Q2 GDP expanded an annualised 1.1%, but the composition was poor, with capex and private consumption both slowing — enough for the yen to firm as traders pushed back the Bank of Japan's next move. Trade policy added another layer of friction: Canada now faces 50% U.S. tariffs on roughly $20 billion of goods, with the bond market waiting on Fed minutes for direction. Geopolitically, the White House instructed the Pentagon to curtail military exercises with South Korea, a decision that reprices Asian defence and regional risk premia in ways the market has barely begun to discount. Oil trod water as U.S.–Iran talks stalled and Strait of Hormuz shipping volumes slowed following tanker attacks.
The AI complex remained the market's centre of gravity but showed its first genuine splintering. With the capex cycle approaching $600 billion, the smart money has stopped agreeing: Tepper added to Nvidia, Loeb exited entirely, and Soros bought. Nvidia itself trimmed its OpenAI Ohio backstop to $120 billion, a subtle but meaningful signal on how much balance-sheet risk the ecosystem's anchor is willing to absorb. Micron cleared $1,000 as the memory trade broadened, though supply chains are fracturing at the component level — a DDR5 patent fight is hitting AI server builders and indium phosphide prices have spiked. Hyperscaler credit scrutiny is emerging as the cycle's new risk vector, and Alphabet's debut kangaroo bond underscores how aggressively Big Tech is diversifying funding away from dollar markets. In private markets, Anthropic and Shein are testing public appetite at reset valuations.
Corporate signals were mixed to cautious. A broad insider-selling wave swept U.S. tech, healthcare and media, historically a late-cycle tell rather than a timing tool, though Goldman's projected $1.4 trillion buyback wave should absorb much of the supply. Australian earnings season turned defensive, with JB Hi-Fi's guidance miss overshadowing a strong Aurizon result and BlueScope's profit more than doubling. a2 Milk was the day's casualty, with FY profit collapsing 44% as a China supply-chain rupture overwhelmed 12% revenue growth. AstraZeneca scrapped its volrustomig lung trial, partly offset by Enhertu data. L3Harris handed the chief executive role to insider Sam Mehta. KKR was rebuffed on First Gen as the Philippine central bank signalled gradual disinflation. Prediction markets and crypto face a widening compliance squeeze, and corporate crypto treasuries diverged sharply, with Bitmine adding Ether while Trump Media walked away from Bitcoin entirely.
The Buy List 2026 model portfolio closed at €111,844 on €110,000 invested, a total return of +1.68%. Leadership remains concentrated in shipping and European industrials: Maersk (+26.4%) continues to carry the book, supported by Vestas (+14.8%), Ole (+14.3%), Ørsted (+8.6%), ASML (+8.2%) and Iberdrola (+8.1%). The drag is narrow but persistent — Vonovia (-16.0%) remains the single largest detractor as German residential real estate struggles with rate expectations, followed by SPCX (-10.6%). Tesla (-3.3%) softened on the Cybercab Austin launch report that rippled through the ride-hailing complex, while Novo Nordisk (-3.7%) and Air Liquide (-2.8%) remained soft. The dispersion is instructive: the portfolio's gains are coming from European capital-goods and energy-transition exposure rather than from the AI trade dominating the headlines.